Connecting you to content on EBSCOhost

Works matching IS 10109609 AND DT 2013 AND VI 27 AND IP 4

Results: 39

1

International Nonproprietary Names for Pharmaceutical Substances (INN)

Published in:: 2013
Publication type:: Journal Article

2

General monograph on parenteral preparations. Test for bacterial endotoxins (3.4)

Published in:: 2013
Publication type:: Journal Article

3

Liposorber Apheresis SystemÂ® approved for paediatric glomerulosclerosis.

Published in:: 2013
Publication type:: Journal Article

4

International Nonproprietary Names for Pharmaceutical Substances (INN).

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 399
Publication type:: Article

5

Fluconazoli injectio.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 395
Publication type:: Article

6

Fluconazoli capsulae.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 392
Publication type:: Article

7

Fluconazoli.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 387
Publication type:: Article

8

Medroxyprogesterone acetate.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 381
Publication type:: Article

9

Sulfamethoxazoli et trimethoprimi infusio intraveno.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 375
Publication type:: Article

10

Niclosamidi compressi.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 375
Publication type:: Article

11

Niclosamide, anhydrous Niclosamide monohydrate.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 374
Publication type:: Article

12

General monograph on parenteral preparations. Test for bacterial endotoxins (3.4).

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 369
Publication type:: Article

13

Dissolution testing of tablets and capsules.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 366
Publication type:: Article

14

International Pharmacopoeia: fourth edition.

Published in:: 2013
Publication type:: Product Review

15

2013 WHO Global Tuberculosis Report.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 364
Publication type:: Article

16

Drug-resistant TB treatments: more support needed.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 364
Publication type:: Article

17

Transparency of clinical trial data.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 363
Publication type:: Article

18

WHO Good Governance for Medicines Model Framework.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 363
Publication type:: Article

19

Sofosbuvir approved for chronic hepatitis C.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 362
Publication type:: Article

20

Delamanid and para-aminosalicylic acid approved for multidrugresistant tuberculosis.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 361
Publication type:: Article

21

Dolutegravir approved for HIV.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 361
Publication type:: Article

22

Eslicarbazepine acetate approved for adult seizures.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 361
Publication type:: Article

23

Ibrutinib approved for mantle cell lymphoma.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 360
Publication type:: Article

24

Lipid injectable emulsion approved for parenteral nutrition.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 360
Publication type:: Article

25

Paclitaxel: expanded use for late-stage pancreatic cancer.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 359
Publication type:: Article

26

Pertuzumab approved as neoadjuvant breast cancer treatment.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 359
Publication type:: Article

27

Vortioxetine approved for major depressive disorder.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 359
Publication type:: Article

28

Riociguat approved for pulmonary hypertension.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 358
Publication type:: Article

29

Liposorber Apheresis System® approved for paediatric glomerulosclerosis.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 358
Publication type:: Article

30

Macitentan approved for pulmonary arterial hypertension.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 357
Publication type:: Article

31

Medical device identification system.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 357
Publication type:: Article

32

EudraGMDP database: improved information-sharing.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 356
Publication type:: Article

33

WHO PQP now charging application fees.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 356
Publication type:: Article

34

EudraCT: new version launched.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 355
Publication type:: Article

35

Helsinki Declaration: 2013 revision.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 355
Publication type:: Article

36

Safety and Efficacy Issues.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 346
Publication type:: Article

37

Quality Assurance of Medicines.

Published in:

WHO Drug Information, 2013, v. 27, n. 4, p. 332

By:

van Zyl, Adriaan J.;
Daviaud, Joelle;
Logez, Sophie

Publication type:

Article

38

WHO Prequalification of Medicines Programme.

Published in:: WHO Drug Information, 2013, v. 27, n. 4, p. 325
Publication type:: Article

39

International Conference of Drug Regulatory Authorities (ICDRA).

Published in:: 2013
Publication type:: Proceeding